"
Profectus BioSciences, Inc. - Product Pipeline Review - 2016 "
is the latest addition to MarketResearchReports.Biz industry research
reports collection.
Global
Markets Directs, Profectus
BioSciences, Inc. - Product Pipeline Review - 2016,
provides an overview of the Profectus BioSciences, Inc.s
pharmaceutical research and development focus.
The
report provides comprehensive information on the therapeutics under
development by Profectus BioSciences, Inc., complete with analysis by
stage of development, drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and the dormant and discontinued
projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Download
Sample copy of this Report @
Scope
-
The report provides a snapshot of the pipeline therapeutic landscape
of Profectus BioSciences, Inc.
-
The report provides overview of Profectus BioSciences, Inc. including
its business
description,
key facts, and locations and subsidiaries
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report assesses Profectus BioSciences, Inc.s pipeline
therapeutics based on drug target, mechanism of action (MoA), route
of administration (RoA) and molecule type
-
The report features Profectus BioSciences, Inc.s out-licensed and
partnered product portfolio and summarizes its dormant and
discontinued projects
Reasons to buy
-
Evaluate Profectus BioSciences, Inc.s strategic position with total
access to detailed information on its product pipeline
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Profectus BioSciences, Inc.
-
Identify potential new clients or partners in the target demographic
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Profectus BioSciences, Inc.s pipeline depth and focus of pipeline
therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Content :
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report
Coverage 6
Profectus BioSciences, Inc.
Snapshot 7
Profectus BioSciences, Inc.
Overview 7
Key Information 7
Key Facts 7
Profectus BioSciences, Inc. -
Research and Development Overview 8
Key Therapeutic Areas 8
Profectus BioSciences, Inc. -
Pipeline Review 11
Pipeline Products by Stage of
Development 11
Pipeline Products - Monotherapy
12
Pipeline Products - Combination
Treatment Modalities 13
Pipeline Products - Partnered
Products 14
Partnered Products/Combination
Treatment Modalities 15
Profectus BioSciences, Inc. -
Pipeline Products Glance 16
Profectus BioSciences, Inc. -
Clinical Stage Pipeline Products 16
Phase I Products/Combination
Treatment Modalities 16
Profectus BioSciences, Inc. -
Early Stage Pipeline Products 17
Preclinical
Products/Combination Treatment Modalities 17
Discovery Products/Combination
Treatment Modalities 18
Profectus BioSciences, Inc. -
Drug Profiles 19
(Ebola + Marburg) (monovalent)
vaccine 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
(Ebola + Marburg) (trivalent)
vaccine 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
HIV [strain C1086] vaccine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
HIV-1 vaccine 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
IHV-001 27
Product Description 27
Mechanism of Action 27
Read
our latest Press Release at
http://www.marketresearchreports.biz/pressreleases
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
us:
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-618-1030
USA:
Canada Toll Free: 866-997-4948
No comments:
Post a Comment